Blueprint Medicines Corp (BPMC)

Blueprint Medicines Corp Azioni (BPMC) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	27.21% 71.96	56.57	57.57	63.29	38.78
Cost Of Revenue	90.65% 0.26	2.782	2.323	3.175	4.848
Gross Profit	33.31% 71.70	53.78	55.25	60.11	33.93
Operating Expenses	3.26% 176.81	182.76	183.23	184.32	183.73
Benefits Costs and Expenses	3.82% 182.81	190.08	190.17	192.33	196.39
Costs And Expenses	4.57% 177.07	185.55	185.55	187.49	188.58
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	18.51% -105.11	-128.98	-127.98	-124.21	-149.80
Net Interest Income/Expense	35.74% -5.169	-3.808	-3.996	-5.819	-9.24
Nonoperating Income/Loss	26.68% -5.746	-4.536	-4.622	-4.833	-7.811
Income/Loss From Continuing Operations Before Tax	16.97% -110.86	-133.52	-132.60	-129.04	-157.61
Income Tax Expense/Benefit	69.04% 0.061	0.197	0.19	0.52	1.036
Income/Loss From Continuing Operations After Tax	17.05% -110.92	-133.71	-132.79	-129.56	-158.65
Net Income/Loss	17.05% -110.92	-133.71	-132.79	-129.56	-158.65
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	299.00% -120.77	60.69	60.52	60.13	0.078
Diluted Average Shares	99.81% 0.113	60.69	60.52	60.13	0.078
Basic Earnings Per Share	16.82% -1.83	-2.20	-2.19	-2.15	-2.65
Diluted Earnings Per Share	17.27% -1.82	-2.20	-2.19	-2.15	-2.65
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-